Abstract:It is generally believed that the etiology of Alzheimer's disease (AD) is closely related to the amyloid-b polypeptides, produced from gamma-secretase cleavage of C99. There is preliminary evidence that cholesterol directly activates gamma-secretase cleavage of C99 through mechanisms that have not been understood so far. In this article, coarse-grained (CG) and all-atom (AT) simulations were employed to investigate the association between C99 and cholesterol, which is essential for our understanding of the role of cholesterol in the amyloidogenic pathway. Firstly, we find that both the N-terminus and the C-terminus of the C99 transmembrane domain (TMD) show interactions with cholesterol. Secondly, a multi-site dynamic cholesterol binding model was captured from the simulations, where 6 binding sites in the C99 TMD were presented. The analyses of the binding energies show that cholesterol prefers the site no. 1, 2, 4 and 5 over others. The most favorable binding energy of nearly -58.857 kJ mol(-1) is from site 1, the repeat GxxxG motif. There are two pathways and two binding states of cholesterol binding to this site. Ser(697) and Phe(690) contribute most to the stabilization of the tightly binding state and the loosely binding state, respectively. The other binding sites described may also be potential drug targets. Thirdly, the residues GAVILMTKF, especially IVKF play a key role in this association. The C99 model appears to suggest a new mechanism for cholesterol binding. Finally, the multiple-site dynamic cholesterol binding model better explains the hypotheses that cholesterol promotes the amyloidogenic AbPP route. The GxxxA motif in the middle of the C99 transmembrane domain is completely exposed without cholesterol sheltering, which might help gamma-secretase identify the cleavage sites and then promote gamma-cleavage. Our results provide a detailed picture of dynamic cholesterol binding, which is crucial to our recognition of the potential influence of cholesterol on the C99 process and the etiology of AD.

Cholesterol Depletion Reduces the Internalization of Β-Amyloid Peptide in SH-SY5Y Cells

Cholesterol Depletion Inhibits the Degradation of Amyloid Β-Peptide in Rat Pheochromocytoma (PC12) Cells

The Interplay Between Cholesterol and Amyloid-β on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling

Cellular cholesterol loss by DHCR24 knockdown leads to Aβ production by changing APP intracellular localization

Cholesterol is an Important Factor Affecting the Membrane Insertion of Β-Amyloid Peptide (aβ1–40), Which May Potentially Inhibit the Fibril Formation

Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword

Reexamining the Causes and Effects of Cholesterol Deposition in the Brains of Patients with Alzheimer’s Disease

Effect of Cholesterol on C99 Dimerization: Revealed by Molecular Dynamics Simulations

Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane

Membrane Localization of β-Amyloid 1–42 in Lysosomes: A POSSIBLE MECHANISM FOR LYSOSOME LABILIZATION

Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol

Membrane Localization of Β-Amyloid 1–42 in Lysosomes

Cholesterol involvement in the pathogenesis of neurodegenerative diseases

Study of Β-Amyloid Peptide (aβ40) Insertion into Phospholipid Membranes Using Monolayer Technique

Aggregation Behavior of Amyloid Beta Peptide Depends Upon the Membrane Lipid Composition

The Dynamic Binding Of Cholesterol To The Multiple Sites Of C99: As Revealed By Coarse-Grained And All-Atom Simulations

The Effects of Extracellular Serum Concentration on APP Processing in Npc1-Deficient APP-Overexpressing N2a Cells

The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo

Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease

Free Cholesterol Induces Higher Beta-Sheet Content in A Beta Peptide Oligomers by Aromatic Interaction with Phe19

Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms